Lyrica (pregabalin) vs. Savella (milnacipran)
Title: Lyrica (pregabalin) vs. Savella (milnacipran)Category: MedicationsCreated: 12/11/2018 12:00:00 AMLast Editorial Review: 12/11/2018 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - December 11, 2018 Category: Drugs & Pharmacology Source Type: news
Lyrica (pregabalin) vs. Cymbalta (duloxetine)
Title: Lyrica (pregabalin) vs. Cymbalta (duloxetine)Category: MedicationsCreated: 12/11/2018 12:00:00 AMLast Editorial Review: 12/11/2018 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - December 11, 2018 Category: Drugs & Pharmacology Source Type: news
Lyrica (pregabalin) vs. Norco (hydrocodone and acetaminophen)
Title: Lyrica (pregabalin) vs. Norco (hydrocodone and acetaminophen)Category: MedicationsCreated: 12/11/2018 12:00:00 AMLast Editorial Review: 12/11/2018 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - December 11, 2018 Category: Drugs & Pharmacology Source Type: news
Lyrica vs. Tramadol
Title: Lyrica vs. TramadolCategory: MedicationsCreated: 12/10/2018 12:00:00 AMLast Editorial Review: 12/10/2018 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - December 10, 2018 Category: Drugs & Pharmacology Source Type: news
Lyrica (pregabalin) vs. Xanax (alprazolam)
Title: Lyrica (pregabalin) vs. Xanax (alprazolam)Category: MedicationsCreated: 12/6/2018 12:00:00 AMLast Editorial Review: 12/6/2018 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - December 6, 2018 Category: Drugs & Pharmacology Source Type: news
UK Supreme Court ruling over pregabalin could cost Pfizer £500m
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - December 1, 2018 Category: Drugs & Pharmacology Source Type: news
Pfizer scores six month extension for Lyrica patent
The FDA has handed a consolation prize to Pfizer, which is on the cusp of completely losing its patent on the company ’s best-selling drug, Lyrica. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - November 29, 2018 Category: Pharmaceuticals Source Type: news
Pfizer loses major patent battle in the U.K.
Lyrica has officially fallen off the patent cliff in Britain. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - November 14, 2018 Category: Pharmaceuticals Source Type: news
Pfizer loses drug patent fight in UK top court, may face claims
Pfizer lost the final round in a lengthy patent battle in Britain on Wednesday after the country's highest court ruled against it in a case involving its $5 billion-a-year pain drug Lyrica, exposing the company to possible financial claims. (Source: Reuters: Health)
Source: Reuters: Health - November 14, 2018 Category: Consumer Health News Tags: healthNews Source Type: news
Pfizer loses blockbuster drug patent fight in UK Supreme Court
Pfizer lost the final round in a long-running patent battle in Britain on Wednesday after the country's highest court ruled against it in a case involving its $5 billion-a-year pain drug Lyrica. (Source: Reuters: Health)
Source: Reuters: Health - November 14, 2018 Category: Consumer Health News Tags: healthNews Source Type: news
Smaller scrips for opioids linked to lower consumption
Quantity of opioids prescribed post-surgery even more strongly linked to higher patient use than pain level Related items fromOnMedica Pregabalin not effective for chronic pain after traumatic nerve injury Prescribe higher dose opioids for shorter time after surgery GP prescribing of opioids is still rising US Painkiller restrictions linked to rise in illegal drug trading England has clear North-South chronic pain divide (Source: OnMedica Latest News)
Source: OnMedica Latest News - November 8, 2018 Category: UK Health Source Type: news
Gabapentin May Top Pregabalin for Sciatica Pain Gabapentin May Top Pregabalin for Sciatica Pain
A comparison of the anticonvulsants gabapentin and pregabalin suggests gabapentin may be superior for pain reduction in chronic sciatica. But at least one expert has concerns about this conclusion.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 17, 2018 Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news
Gabapentin Beats Pregabalin for Chronic Sciatica
WEDNESDAY, Oct. 17, 2018 -- For patients with chronic sciatica (CS), gabapentin (GBP) is superior to pregabalin (PGB), with fewer and less severe adverse events (AEs), according to a study published online Oct. 15 in JAMA Neurology.
Kelvin... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - October 17, 2018 Category: Pharmaceuticals Source Type: news
Q-Collar Compression; New Views of Alzheimer's; Gabapentin vs. Pregabalin
(MedPage Today) -- News and commentary from the world of neurology and neuroscience (Source: MedPage Today Psychiatry)
Source: MedPage Today Psychiatry - October 16, 2018 Category: Psychiatry Source Type: news
‘Patients Deserve to Know’: Trump Administration Wants Drug Commercials to Show Prices
TRENTON, N.J. — The federal government said Monday that it wants to force drugmakers to disclose prices for prescription medicines in their TV commercials.
The drug industry’s main trade group said drug companies are only willing to disclose the prices on their websites, not in commercials, and they’ll start doing that next spring.
Health and Human Services Secretary Alex Azar unveiled a proposal that would apply to all brand-name drugs covered by the Medicare and Medicaid programs, which is most medicines.
“Patients deserve to know what a given drug could cost when they’re being told about th...
Source: TIME: Health - October 16, 2018 Category: Consumer Health News Authors: LINDA A. JOHNSON / AP Tags: Uncategorized Healthcare onetime Source Type: news
